RareCyte® launched its first commercial product in 2015 with the release of the CyteFinder® Instrument. The CyteFinder along with the revolutionary AccuCyte® Sample Preparation System have seen worldwide adoption with placements at academic medical centers, contract research organizations, and biopharma companies. In 2018, RareCyte moved to their current 22,000 ft2 lab and office facility in Seattle, WA and expanded regulatory and clinical development capability to support companion diagnostics (CDx) partnership programs with biopharma.
A dedicated team focused on an important challenge
Headquartered in Seattle, RareCyte is an innovative life science company that has developed technologies for the analysis of rare single cells in blood. Our end-to-end integrated platform for rare cell analysis includes consumables, instrumentation, analysis software, and cell retrieval capabilities that enable advances in oncology, immuno-oncology, maternal-fetal health, and more.
Our interdisciplinary team of scientists and engineers are dedicated to designing products that advance biomedical research and contribute to companion diagnostic development.
Please visit the Products and Solutions pages for more information on our technology and the Applications pages for a description of how our systems are being utilized by customers.